John Gill

Insider Reports History

Location
C/O Pharmathene, Inc, One Park Place, Suite 450, Annapolis, MD
Signature
/s/ Gregory Weaver, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Gill:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Altimmune, Inc. Director Common Stock, par value $0.0001 0 $0 $3.71 Jan 6, 2022 Direct
Altimmune, Inc. Director Stock Options (option to buy) 48.8K Sep 25, 2025 Direct

Insider Reports Filed by John Gill

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALT Altimmune, Inc. Sep 25, 2025 2 $0 4 Sep 29, 2025 Director
ALT Altimmune, Inc. Sep 26, 2024 1 $0 4 Sep 30, 2024 Director
ALT Altimmune, Inc. Sep 28, 2023 1 $0 4 Sep 29, 2023 Director
ALT Altimmune, Inc. Sep 29, 2022 1 $0 4 Sep 30, 2022 Director
ALT Altimmune, Inc. Aug 12, 2022 1 -$40.7K 4 Jul 6, 2023 Director
ALT Altimmune, Inc. Dec 31, 2021 3 $0 5 Feb 14, 2022 Director
ALT Altimmune, Inc. Sep 23, 2021 1 $0 4 Sep 24, 2021 Director